BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24231715)

  • 1. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
    Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin-related thrombocytopenia.
    Jardim DL; Rodrigues CA; Novis YAS; Rocha VG; Hoff PM
    Ann Oncol; 2012 Aug; 23(8):1937-1942. PubMed ID: 22534771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
    Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
    Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report.
    Baretta Z; Falci C; Piva E; Conte P
    Clin Colorectal Cancer; 2013 Dec; 12(4):294-6. PubMed ID: 24188688
    [No Abstract]   [Full Text] [Related]  

  • 6. Sudden-onset thrombocytopenia with oxaliplatin.
    Dold FG; Mitchell EP
    Ann Intern Med; 2003 Jul; 139(2):E156. PubMed ID: 12859182
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
    Sørbye H; Bruserud Y; Dahl O
    Acta Oncol; 2001; 40(7):882-3. PubMed ID: 11859992
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
    Shao YY; Hong RL
    Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
    James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
    Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin-induced acute thrombocytopenia.
    Erdem GU; Dogan M; Demirci NS; Zengin N
    J Cancer Res Ther; 2016; 12(2):509-14. PubMed ID: 27461601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment continuation with a single mild partial splenic embolization for thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colon cancer.
    Heianna J; Muto O; Miyauchi T; Endo W; Togashi A; Azama K; Murayama S
    Indian J Gastroenterol; 2016 May; 35(3):245-7. PubMed ID: 27230031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report.
    Santodirocco M; Lombardi V; Fesce C; Palumbo G; Capalbo S; Landriscina M
    Acta Oncol; 2008; 47(8):1602-4. PubMed ID: 18607839
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
    Curtis BR; Kaliszewski J; Marques MB; Saif MW; Nabelle L; Blank J; McFarland JG; Aster RH
    Am J Hematol; 2006 Mar; 81(3):193-8. PubMed ID: 16493620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin-induced renal tubular vacuolization.
    Joybari AY; Sarbaz S; Azadeh P; Mirafsharieh SA; Rahbari A; Farasatinasab M; Mokhtari M
    Ann Pharmacother; 2014 Jun; 48(6):796-800. PubMed ID: 24615628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
    Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
    Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation recall with oxaliplatin: report of a case and a review of the literature.
    Chan RT; Au GK; Ho JW; Chu KW
    Clin Oncol (R Coll Radiol); 2001; 13(1):55-7. PubMed ID: 11292139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.
    Overman MJ; Maru DM; Charnsangavej C; Loyer EM; Wang H; Pathak P; Eng C; Hoff PM; Vauthey JN; Wolff RA; Kopetz S
    J Clin Oncol; 2010 May; 28(15):2549-55. PubMed ID: 20406923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
    Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
    Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization.
    Tuttle KL; Stavrou E; Hong DIC; Connell NT; Wickner P
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):267-269. PubMed ID: 33971363
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.
    Pietrantonio F; Di Bartolomeo M; Buzzoni R; Bajetta E
    Tumori; 2010; 96(1):154-6. PubMed ID: 20437874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.